skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 101,941  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Show only
Refined by: subject: Chemotherapy remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
Material Type:
Article 		Add to My Research

Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer

International journal of clinical oncology, 2020-01, Vol.25 (1), p.1-42 [Peer Reviewed Journal]

The Author(s) 2019 ;International Journal of Clinical Oncology is a copyright of Springer, (2019). All Rights Reserved. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1341-9625 ;EISSN: 1437-7772 ;DOI: 10.1007/s10147-019-01485-z ;PMID: 31203527

Full text available

Citations Cited by
2
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer
Material Type:
Article 		Add to My Research

Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer

The New England journal of medicine, 2023-06, Vol.388 (23), p.2159-2170 [Peer Reviewed Journal]

Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;Copyright © 2023 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2302312 ;PMID: 36972022

Full text available

Citations Cited by
3
ALIGNING COMPLIANCE OF CHEMOTHERAPY SECOND SIGNATURE ORDERS IN THE AMBULATORY TREATMENT CENTERS
ALIGNING COMPLIANCE OF CHEMOTHERAPY SECOND SIGNATURE ORDERS IN THE AMBULATORY TREATMENT CENTERS
Material Type:
Article 		Add to My Research

ALIGNING COMPLIANCE OF CHEMOTHERAPY SECOND SIGNATURE ORDERS IN THE AMBULATORY TREATMENT CENTERS

Oncology nursing forum, 2023-03, Vol.50 (2), p.C26-C27 [Peer Reviewed Journal]

Copyright Oncology Nursing Society Mar 2023 ;ISSN: 0190-535X ;EISSN: 1538-0688

Full text available

Citations Cited by
4
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer
Material Type:
Article 		Add to My Research

Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer

The New England journal of medicine, 2023-06, Vol.388 (23), p.2145-2158 [Peer Reviewed Journal]

Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;Copyright © 2023 Massachusetts Medical Society. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2216334 ;PMID: 36972026

Full text available

Citations Cited by
5
A COVID-19 screening tool for oncology telephone triage
A COVID-19 screening tool for oncology telephone triage
Material Type:
Article 		Add to My Research

A COVID-19 screening tool for oncology telephone triage

Supportive care in cancer, 2021-04, Vol.29 (4), p.2057-2062 [Peer Reviewed Journal]

Springer-Verlag GmbH Germany, part of Springer Nature 2020 ;COPYRIGHT 2021 Springer ;Springer-Verlag GmbH Germany, part of Springer Nature 2020. ;ISSN: 0941-4355 ;EISSN: 1433-7339 ;DOI: 10.1007/s00520-020-05713-5 ;PMID: 32856214

Full text available

Citations Cited by
6
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
Material Type:
Article 		Add to My Research

2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)

European heart journal, 2022-11, Vol.43 (41), p.4229-4361 [Peer Reviewed Journal]

Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0195-668X ;ISSN: 1522-9645 ;EISSN: 1522-9645 ;DOI: 10.1093/EURHEARTJ/EHAC244 ;PMID: 36017568

Full text available

Citations Cited by
7
New Horizons in the Treatment of Osteosarcoma
New Horizons in the Treatment of Osteosarcoma
Material Type:
Article 		Add to My Research

New Horizons in the Treatment of Osteosarcoma

The New England journal of medicine, 2021-11, Vol.385 (22), p.2066-2076 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;COPYRIGHT 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMra2103423

Full text available

Citations Cited by
8
21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer
21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer
Material Type:
Article 		Add to My Research

21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer

The New England journal of medicine, 2021-12, Vol.385 (25), p.2336-2347 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2108873 ;PMID: 34914339

Full text available

Citations Cited by
9
Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer
Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer
Material Type:
Article 		Add to My Research

Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer

The New England journal of medicine, 2023-05, Vol.388 (18), p.1645-1656 [Peer Reviewed Journal]

Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;Copyright © 2023 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2212856 ;PMID: 37133584

Full text available

Citations Cited by
10
Epithelial ovarian cancer: Evolution of management in the era of precision medicine
Epithelial ovarian cancer: Evolution of management in the era of precision medicine
Material Type:
Article 		Add to My Research

Epithelial ovarian cancer: Evolution of management in the era of precision medicine

CA: a cancer journal for clinicians, 2019-07, Vol.69 (4), p.280-304 [Peer Reviewed Journal]

2019 The Authors. CA A Cancer Journal for Clinicians published by Wiley Periodicals, Inc. on behalf of American Cancer Society. ;Copyright Wiley Subscription Services, Inc. Jul/Aug 2019 ;ISSN: 0007-9235 ;EISSN: 1542-4863 ;DOI: 10.3322/caac.21559 ;PMID: 31099893

Full text available

Citations Cited by
11
Serpentine Supravenous Hyperpigmentation
Serpentine Supravenous Hyperpigmentation
Material Type:
Article 		Add to My Research

Serpentine Supravenous Hyperpigmentation

The New England journal of medicine, 2022-12, Vol.387 (25), p.e67 [Peer Reviewed Journal]

Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMicm2207158 ;PMID: 36546629

Full text available

Citations Cited by
12
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer
Material Type:
Article 		Add to My Research

Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer

The New England journal of medicine, 2021-11, Vol.385 (20), p.1856-1867 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2112435 ;PMID: 34534429

Full text available

Citations Cited by
13
Perioperative Nivolumab and Chemotherapy in Stage III Non–Small-Cell Lung Cancer
Perioperative Nivolumab and Chemotherapy in Stage III Non–Small-Cell Lung Cancer
Material Type:
Article 		Add to My Research

Perioperative Nivolumab and Chemotherapy in Stage III Non–Small-Cell Lung Cancer

The New England journal of medicine, 2023-08, Vol.389 (6), p.504-513 [Peer Reviewed Journal]

Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;Copyright © 2023 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2215530 ;PMID: 37379158

Full text available

Citations Cited by
14
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
Material Type:
Article 		Add to My Research

Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update

Archives of pathology & laboratory medicine (1976), 2018-11, Vol.142 (11), p.1364-1382 [Peer Reviewed Journal]

COPYRIGHT 2018 College of American Pathologists ;Copyright College of American Pathologists Nov 2018 ;ISSN: 0003-9985 ;ISSN: 1543-2165 ;EISSN: 1543-2165 ;DOI: 10.5858/arpa.2018-0902-sa ;PMID: 29846104

Full text available

Citations Cited by
15
Quality indicators for advanced ovarian cancer surgery from the European Society of Gynaecological Oncology (ESGO): 2020 update
Quality indicators for advanced ovarian cancer surgery from the European Society of Gynaecological Oncology (ESGO): 2020 update
Material Type:
Article 		Add to My Research

Quality indicators for advanced ovarian cancer surgery from the European Society of Gynaecological Oncology (ESGO): 2020 update

International journal of gynecological cancer, 2020-04, Vol.30 (4), p.436-440 [Peer Reviewed Journal]

IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;2020 by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology. ;2020 IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2020-001248 ;PMID: 32086362

Full text available

Citations Cited by
16
Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcoma
Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcoma
Material Type:
Article 		Add to My Research

Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcoma

PloS one, 2010-05, Vol.5 (5), p.e10764 [Peer Reviewed Journal]

COPYRIGHT 2010 Public Library of Science ;COPYRIGHT 2010 Public Library of Science ;2010 Susa et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Susa et al. 2010 ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0010764 ;PMID: 20520719

Full text available

Citations Cited by
17
Does Breast-Conserving Surgery with Radiotherapy have a Better Survival than Mastectomy? A Meta-Analysis of More than 1,500,000 Patients
Does Breast-Conserving Surgery with Radiotherapy have a Better Survival than Mastectomy? A Meta-Analysis of More than 1,500,000 Patients
Material Type:
Article 		Add to My Research

Does Breast-Conserving Surgery with Radiotherapy have a Better Survival than Mastectomy? A Meta-Analysis of More than 1,500,000 Patients

Annals of surgical oncology, 2022-10, Vol.29 (10), p.6163-6188 [Peer Reviewed Journal]

Society of Surgical Oncology 2022 ;Society of Surgical Oncology 2022. ;ISSN: 1068-9265 ;EISSN: 1534-4681 ;DOI: 10.1245/s10434-022-12133-8

Full text available

Citations Cited by
18
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial
Material Type:
Article 		Add to My Research

Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial

The lancet oncology, 2016-10, Vol.17 (10), p.1396-1408 [Peer Reviewed Journal]

The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY license ;2016 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY license ;Copyright © 2016 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY license. Published by Elsevier Ltd.. All rights reserved. ;Copyright Elsevier Limited Oct 01, 2016 ;2016 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY license 2016 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(16)30214-5 ;PMID: 27569442 ;CODEN: LANCAO

Full text available

Citations Cited by
19
Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma
Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma
Material Type:
Article 		Add to My Research

Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma

The New England journal of medicine, 2022-12, Vol.387 (23), p.2113-2125 [Peer Reviewed Journal]

Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;COPYRIGHT 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2210233 ;PMID: 36477031

Full text available

Citations Cited by
20
Dabrafenib plus trametinib in patients with previously treated BRAFV600E -mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial
Dabrafenib plus trametinib in patients with previously treated BRAFV600E -mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial
Material Type:
Article 		Add to My Research

Dabrafenib plus trametinib in patients with previously treated BRAFV600E -mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial

The lancet oncology, 2016-07, Vol.17 (7), p.984-993 [Peer Reviewed Journal]

Elsevier Ltd ;2016 Elsevier Ltd ;Copyright Elsevier Limited Jul 01, 2016 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(16)30146-2 ;CODEN: LANCAO

Full text available

Citations Cited by

Results 1 - 20 of 101,941  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (94,049)

Refine My Results

Creation Date 

From To
Refine
  1. Before 1980  (121)
  2. 1980 To 1990  (2,902)
  3. 1991 To 2001  (10,156)
  4. 2002 To 2013  (18,791)
  5. After 2013  (70,038)
  6. More options open sub menu

Subject 

  1. Oncology  (97,099)
  2. Science & Technology  (95,901)
  3. Life Sciences & Biomedicine  (93,487)
  4. Humans  (55,950)
  5. Cancer Therapies  (38,064)
  6. Female  (34,994)
  7. Patients  (33,611)
  8. Cancer  (33,467)
  9. Tumors  (32,512)
  10. Metastasis  (26,231)
  11. Middle Aged  (24,786)
  12. Male  (24,651)
  13. Medical Prognosis  (24,571)
  14. Aged  (21,146)
  15. Adult  (19,910)
  16. Care And Treatment  (19,206)
  17. Biological And Medical Sciences  (18,982)
  18. Medical Sciences  (18,808)
  19. Radiation Therapy  (17,445)
  20. More options open sub menu

Language 

  1. English  (101,577)
  2. Japanese  (11,101)
  3. Turkish  (197)
  4. Chinese  (164)
  5. German  (108)
  6. French  (107)
  7. Portuguese  (74)
  8. Norwegian  (65)
  9. Spanish  (42)
  10. Russian  (40)
  11. Polish  (33)
  12. Italian  (3)
  13. Korean  (3)
  14. Afrikaans  (2)
  15. Catalan  (1)
  16. Arabic  (1)
  17. Bosnian  (1)
  18. Romanian  (1)
  19. Dutch  (1)
  20. Persian  (1)
  21. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait